Azzad Asset Management »

Halozyme Therapeutics shares owned by Azzad Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Azzad Asset Management from 13F filings

Historical chart of Azzad Asset Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Azzad Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Azzad Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $816k 12k 67.30
2025-09-30 $875k 12k 73.34

More positions owned by Azzad Asset Management

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Kla Corp Com New (KLAC)
Broadcom (AVGO)
Merck & Co (MRK)
Lam Research Corp Com New (LRCX)
Expeditors International of Washington (EXPD)
Procter & Gamble Company (PG)
Cardinal Health (CAH)
Anglogold Ashanti Com Shs (AU)
International Business Machines (IBM)

View all positions for Azzad Asset Management

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Invesco
Arrowstreet Capital, Limited Partnership
D. E. Shaw & Co
Geode Capital Management
Snyder Capital Management
Dimensional Fund Advisors
Alliancebernstein
Norges Bank Investment Management
William Blair Investment Management
Federated Investors
Jupiter Asset Management
Wells Fargo & Company

View all funds holding Halozyme Therapeutics